{
    "clinical_study": {
        "@rank": "110856", 
        "arm_group": [
            {
                "arm_group_label": "Experimental", 
                "arm_group_type": "Experimental", 
                "description": "6 weeks of inspiratory muscle training, 6 days per week.  The intensity of training will be equivalent to up to 50% of pre-training maximal inspiratory mouth pressure and will be adapted weekly to reflect the improvement in inspiratory muscle strength"
            }, 
            {
                "arm_group_label": "Sham Comparator", 
                "arm_group_type": "Sham Comparator", 
                "description": "6 weeks of sham inspiratory muscle training, 6 days per week.  The intensity of training will be equivalent to 5% of pre-training inspiratory mouth pressure throughout the 6 week period."
            }
        ], 
        "brief_summary": {
            "textblock": "This is a pilot study which will assess the feasibility of a follow on main study.  This\n      study will examine the impact of inspiratory muscle training on quality of life, rescue drug\n      medication usage, and other markers of asthma in adult asthmatics in the UK."
        }, 
        "brief_title": "Inspiratory Muscle Training and Asthma", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Asthma", 
        "condition_browse": {
            "mesh_term": [
                "Respiratory Aspiration", 
                "Asthma"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Asthma Control Questionnaire score of \u2265 1.5\n\n          -  10 mg or less of prednisolone (or equivalent) daily\n\n          -  Aged 18 to 59 years inclusive\n\n          -  Able to provide written informed consent\n\n        Exclusion Criteria:\n\n          -  Any significant heart or lung disease other than asthma including any previous\n             history of pneumothorax\n\n          -  Patients with a concomitant  condition (including clinically relevant cardiovascular,\n             hepatic, neurological, endocrine, or other major systemic disease) not controlled\n             with treatment, making implementation of the protocol or interpretation of the study\n             results difficult\n\n          -  Women who are pregnant\n\n          -  Forced expiratory volume in one second of less than 50% best or predicted\n\n          -  A history of smoking 20 cigarettes a day for 20 years or more (or an equivalent\n             amount)\n\n          -  Undertaken a structured program of inspiratory muscle training within the past three\n             months\n\n          -  Currently a participant in another interventional study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "59 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 7, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01727765", 
            "org_study_id": "IMT and Asthma"
        }, 
        "intervention": {
            "arm_group_label": [
                "Experimental", 
                "Sham Comparator"
            ], 
            "description": "Both groups will undertake six weeks of inspiratory muscle training (POWERbreathe, H&B International Ltd, UK), six days per week, with the only difference being the load set on the inspiratory muscle training device.  For the real inspiratory muscle training group this load will be set to around 50% of maximal inspiratory mouth pressure and for the sham inspiratory muscle training group this load will be set to around 5% of maximal inspiratory mouth pressure.", 
            "intervention_name": "inspiratory muscle training", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Asthma, inspiratory muscle training", 
        "lastchanged_date": "February 12, 2014", 
        "location": [
            {
                "contact": {
                    "email": "anoop.chauahn@porthosp.nhs.uk", 
                    "last_name": "Anoop Chauhan", 
                    "phone": "+440232286000"
                }, 
                "contact_backup": {
                    "email": "olivia.scullionwinn@porthosp.nhs.uk", 
                    "last_name": "Olivia Scullion-Winn", 
                    "phone": "+440232286000"
                }, 
                "facility": {
                    "address": {
                        "city": "Portsmouth", 
                        "country": "United Kingdom", 
                        "state": "Hampshire", 
                        "zip": "PO6 3LY"
                    }, 
                    "name": "Respiratory Centre, Queen Alexandra Hospital, Cosham"
                }, 
                "investigator": {
                    "last_name": "Anoop Chauhan", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mitch.lomax@port.ac.uk", 
                    "last_name": "Mitch Lomax", 
                    "phone": "+4402392845297"
                }, 
                "contact_backup": {
                    "email": "jan.shute@port.ac.uk", 
                    "last_name": "Janis Shute", 
                    "phone": "+4402392842152"
                }, 
                "facility": {
                    "address": {
                        "city": "Portsmouth", 
                        "country": "United Kingdom", 
                        "state": "Hampshire", 
                        "zip": "PO6 3LY"
                    }, 
                    "name": "University of Portsmouth"
                }, 
                "investigator": [
                    {
                        "last_name": "Mitch Lomax", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Janis Shute", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "Inspiratory Muscle Training as a Novel Approach in the Treatment of Asthma", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Two weeks at the start of the study (post informed consent) will be required for diary completion (asthma control diary; Asthma Quality of Life Questionnaire with Standardised Activities).\nOne week for pre-intervention testing (body plethysmography, exhaled nitric oxide, blood immunoglobulin G, respiratory muscle strength).\nSix weeks of inspiratory muscle training (details provided elsewhere).\nOne week for post-intervention testing (plethysmography, exhaled nitric oxide, blood immunoglobulin G, respiratory muscle strength).\nTwo weeks will be required towards the end of inspiratory muscle training for diary completion (asthma control diary; Asthma Quality of Life Questionnaire with Standardised Activities).  This two week period will coincide with the final week of inspiratory muscle training and the first week following it.", 
            "measure": "Assess the feasibility of the methods adopted", 
            "safety_issue": "No", 
            "time_frame": "This will depend on when ethical approval is received.  Participants will be actively engaged for 11 or 12  weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01727765"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Portsmouth", 
            "investigator_full_name": "Mitch Lomax", 
            "investigator_title": "Senior Lecturer", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Portsmouth", 
        "sponsors": {
            "collaborator": {
                "agency": "National Health Service, United Kingdom", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Portsmouth", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}